Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 62,384 | 42,069 | 36,527 | 24,860 | 37,042 |
| Gross Profit | 62,384 | 42,069 | 36,527 | 24,860 | 37,042 |
| Operating Expenses | 173,673 | 187,664 | 150,700 | 135,931 | 95,232 |
| Operating Income | -111,289 | -145,595 | -114,173 | -111,071 | -58,190 |
| Other Income | 9,699 | 15,501 | 12,563 | 2,949 | 247 |
| Pre-tax Income | -101,590 | -130,094 | -101,610 | -108,122 | -57,943 |
| Income Tax | 4 | 208 | 134 | 54 | 292 |
| Net Income Continuous | -101,594 | -130,302 | -101,744 | -108,176 | -58,235 |
| Net Income | $-101,594 | $-130,302 | $-101,744 | $-108,176 | $-58,235 |
| EPS Basic Total Ops | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EPS Basic Continuous Ops | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EPS Diluted Total Ops | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EPS Diluted Continuous Ops | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EBITDA(a) | $-111,696 | $-147,713 | $-115,152 | $-109,463 | $-57,293 |